340 related articles for article (PubMed ID: 11682446)
41. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
42. 1,4-Cyclohexanecarboxylates: potent and selective inhibitors of phosophodiesterase 4 for the treatment of asthma.
Christensen SB; Guider A; Forster CJ; Gleason JG; Bender PE; Karpinski JM; DeWolf WE; Barnette MS; Underwood DC; Griswold DE; Cieslinski LB; Burman M; Bochnowicz S; Osborn RR; Manning CD; Grous M; Hillegas LM; Bartus JO; Ryan MD; Eggleston DS; Haltiwanger RC; Torphy TJ
J Med Chem; 1998 Mar; 41(6):821-35. PubMed ID: 9526558
[TBL] [Abstract][Full Text] [Related]
43. Therapeutic intervention in a rat model of ARDS: IV. Phosphodiesterase IV inhibition.
Turner CR; Esser KM; Wheeldon EB
Circ Shock; 1993 Mar; 39(3):237-45. PubMed ID: 8384094
[TBL] [Abstract][Full Text] [Related]
44. Tumor necrosis factor is not associated with intestinal ischemia/reperfusion-induced lung inflammation.
Soares AL; Coelho FR; Guabiraba R; Kamal M; Vargaftig BB; Li L; Li J; Tavares-de-Lima W; Ryffel B
Shock; 2010 Sep; 34(3):306-13. PubMed ID: 20160673
[TBL] [Abstract][Full Text] [Related]
45. The role of proinflammatory cytokines in lung ischemia-reperfusion injury.
Krishnadasan B; Naidu BV; Byrne K; Fraga C; Verrier ED; Mulligan MS
J Thorac Cardiovasc Surg; 2003 Feb; 125(2):261-72. PubMed ID: 12579094
[TBL] [Abstract][Full Text] [Related]
46. Subthreshold doses of nebulized prostacyclin and rolipram synergistaically protect against lung ischemia-reperfusion.
Schütte H; Schell A; Schäfer C; Ghofrani A; Theo Schermuly R; Seeger W; Grimminger F
Transplantation; 2003 Mar; 75(6):814-21. PubMed ID: 12660508
[TBL] [Abstract][Full Text] [Related]
47. Studies on mechanisms of low emetogenicity of YM976, a novel phosphodiesterase type 4 inhibitor.
Aoki M; Fukunaga M; Sugimoto T; Hirano Y; Kobayashi M; Honda K; Yamada T
J Pharmacol Exp Ther; 2001 Sep; 298(3):1142-9. PubMed ID: 11504812
[TBL] [Abstract][Full Text] [Related]
48. Phosphodiesterase 4 inhibitors prevent cytokine secretion by T lymphocytes by inhibiting nuclear factor-kappaB and nuclear factor of activated T cells activation.
Jimenez JL; Punzón C; Navarro J; Muñoz-Fernández MA; Fresno M
J Pharmacol Exp Ther; 2001 Nov; 299(2):753-9. PubMed ID: 11602691
[TBL] [Abstract][Full Text] [Related]
49. Local anti-inflammatory effect and behavioral studies on new PDE4 inhibitors.
Pieretti S; Dominici L; Di Giannuario A; Cesari N; Dal Piaz V
Life Sci; 2006 Jul; 79(8):791-800. PubMed ID: 16546218
[TBL] [Abstract][Full Text] [Related]
50. The phosphodiesterase type 4 (PDE4) inhibitor CP-80,633 elevates plasma cyclic AMP levels and decreases tumor necrosis factor-alpha (TNFalpha) production in mice: effect of adrenalectomy.
Cheng JB; Watson JW; Pazoles CJ; Eskra JD; Griffiths RJ; Cohan VL; Turner CR; Showell HJ; Pettipher ER
J Pharmacol Exp Ther; 1997 Feb; 280(2):621-6. PubMed ID: 9023272
[TBL] [Abstract][Full Text] [Related]
51. A comparison of the inhibitory activity of PDE4 inhibitors on leukocyte PDE4 activity in vitro and eosinophil trafficking in vivo.
Cooper N; Teixeira MM; Warneck J; Miotla JM; Wills RE; Macari DM; Gristwood RW; Hellewell PG
Br J Pharmacol; 1999 Apr; 126(8):1863-71. PubMed ID: 10372831
[TBL] [Abstract][Full Text] [Related]
52. Enhanced protection from renal ischemia-reperfusion [correction of ischemia:reperfusion] injury with A(2A)-adenosine receptor activation and PDE 4 inhibition.
Okusa MD; Linden J; Huang L; Rosin DL; Smith DF; Sullivan G
Kidney Int; 2001 Jun; 59(6):2114-25. PubMed ID: 11380813
[TBL] [Abstract][Full Text] [Related]
53. Role of the bradykinin B2 receptor for the local and systemic inflammatory response that follows severe reperfusion injury.
Souza DG; Pinho V; Pesquero JL; Lomez ES; Poole S; Juliano L; Correa A; de A Castro MS; Teixeira MM
Br J Pharmacol; 2003 May; 139(1):129-39. PubMed ID: 12746231
[TBL] [Abstract][Full Text] [Related]
54. Cyclic nucleotide phosphodiesterase type IV participates in the regulation of IL-10 and in the subsequent inhibition of TNF-alpha and IL-6 release by endotoxin-stimulated macrophages.
Kambayashi T; Jacob CO; Zhou D; Mazurek N; Fong M; Strassmann G
J Immunol; 1995 Nov; 155(10):4909-16. PubMed ID: 7594495
[TBL] [Abstract][Full Text] [Related]
55. Effects of PKF242-484 and PKF241-466, novel dual inhibitors of TNF-alpha converting enzyme and matrix metalloproteinases, in a model of intestinal reperfusion injury in mice.
Souza DG; Ferreira FL; Fagundes CT; Amaral FA; Vieira AT; Lisboa RA; Andrade MV; Trifilieff A; Teixeira MM
Eur J Pharmacol; 2007 Sep; 571(1):72-80. PubMed ID: 17619015
[TBL] [Abstract][Full Text] [Related]
56. Evidence that cyclic AMP phosphodiesterase inhibitors suppress TNF alpha generation from human monocytes by interacting with a 'low-affinity' phosphodiesterase 4 conformer.
Souness JE; Griffin M; Maslen C; Ebsworth K; Scott LC; Pollock K; Palfreyman MN; Karlsson JA
Br J Pharmacol; 1996 Jun; 118(3):649-58. PubMed ID: 8762090
[TBL] [Abstract][Full Text] [Related]
57. Evidence for a role of phosphodiesterase 4 in lipopolysaccharide-stimulated prostaglandin E2 production and matrix metalloproteinase-9 activity in human amniochorionic membranes.
Oger S; Méhats C; Dallot E; Cabrol D; Leroy MJ
J Immunol; 2005 Jun; 174(12):8082-9. PubMed ID: 15944316
[TBL] [Abstract][Full Text] [Related]
58. Mechanisms of the anti-inflammatory effects of the natural secosteroids physalins in a model of intestinal ischaemia and reperfusion injury.
Vieira AT; Pinho V; Lepsch LB; Scavone C; Ribeiro IM; Tomassini T; Ribeiro-dos-Santos R; Soares MB; Teixeira MM; Souza DG
Br J Pharmacol; 2005 Sep; 146(2):244-51. PubMed ID: 16025143
[TBL] [Abstract][Full Text] [Related]
59. Repertaxin, a novel inhibitor of rat CXCR2 function, inhibits inflammatory responses that follow intestinal ischaemia and reperfusion injury.
Souza DG; Bertini R; Vieira AT; Cunha FQ; Poole S; Allegretti M; Colotta F; Teixeira MM
Br J Pharmacol; 2004 Sep; 143(1):132-42. PubMed ID: 15302676
[TBL] [Abstract][Full Text] [Related]
60. Suppression of anti-CD3-induced interleukin-4 and interleukin-5 release from splenocytes of Mesocestoides corti-infected BALB/c mice by phosphodiesterase 4 inhibitors.
Souness JE; Houghton C; Sardar N; Withnall MT
Biochem Pharmacol; 1999 Sep; 58(6):991-9. PubMed ID: 10509751
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
